The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications
Open accessAbstract
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement therapy approach have proven to be very powerful and instrumental in biomedical research and personalized regenerative medicine as evidenced in the past decade by unraveling novel pathological mechanisms of a multitude of monogenic diseases at the cellular level and the ongoing and emerging clinical trials with iPSC-derived cell products. iPSC-based disease modelling has sparked widespread enthusiasm and has presented an unprecedented opportunity in high throughput drug discovery platforms and safety pharmacology in association with three-dimensional multicellular organoids such as personalized organs-on-chips, gene/base editing, artificial intelligence and high throughput “omics” methodologies. This critical review summarizes the progress made in the past decade with the advent of iPSC discovery in biomedical applications and regenerative medicine with case examples and the current major challenges that need to be addressed to unleash the full potential of iPSCs in clinical settings and pharmacology for more effective and safer regenerative therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there are no standardized requirements for systems implemented and protocols used, leading to differing process effectiveness, robustness, and outcomes90,91.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [90]
In the citing paper
“A set of minimal quality criteria does exist for constitution of a clinical-grade iPSC-derived therapeutic throughout the pipeline”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [90]
In the citing paper
“while a framework exists for therapeutic generation through CGMP”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [90]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310
Establishment in culture of pluripotential cells from mouse embryos
Evans, M. J., & Kaufman, M. H. (1981) · Nature · doi:10.1038/292154a0 · Cited by 8,607
Martin, G. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7634 · Cited by 5,746
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Human induced pluripotent stem cells free of vector and transgene sequences
Yu, J., Hu, K., Smuga-Otto, K., Tian, S., Stewart, R., Slukvin, I. I., & Thomson, J. A. (2009) · Science · doi:10.1126/science.1172482 · Cited by 2,386
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Epigenetic memory in induced pluripotent stem cells
Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., et al. (2010) · Nature · doi:10.1038/nature09342 · Cited by 2,313
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061
piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells
Woltjen, K., Michael, I. P., Mohseni, P., Desai, R., Mileikovsky, M., Hämäläinen, R., Cowling, R., Wang, W., Liu, P., Gertsenstein, M., et al. (2009) · Nature · doi:10.1038/nature07863 · Cited by 1,814
Induced pluripotent stem cells generated without viral integration
Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G., & Hochedlinger, K. (2008) · Science · doi:10.1126/science.1162494 · Cited by 1,683
Induced pluripotent stem cell technology: a decade of progress.
Shi, Y., Inoue, H., Wu, J. C., & Yamanaka, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.245 · Cited by 1,525
Autologous Induced Stem-Cell–Derived Retinal Cells for Macular Degeneration
Mandai, M., Watanabe, A., Kurimoto, Y., Hirami, Y., Morinaga, C., Daimon, T., Fujihara, M., Akimaru, H., Sakai, N., Shibata, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1608368 · Cited by 1,509
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes
Aasen, T., Raya, A., Barrero, M. J., Garreta, E., Consiglio, A., Gonzalez, F., Vassena, R., Bilić, J., Pekarik, V., Tiscornia, G., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt.1503 · Cited by 1,423
In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes
Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J.-D., & Srivastava, D. (2012) · Nature · doi:10.1038/nature11044 · Cited by 1,360
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1667 · Cited by 1,198
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells
Doetschman, T., Gregg, R. G., Maeda, N., Hooper, M. L., Melton, D. W., Thompson, S., & Smithies, O. (1987) · Nature · doi:10.1038/330576a0 · Cited by 786
Human iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
Mertens, J., Paquola, A. C. M., Ku, M., Hatch, E., Böhnke, L., Ladjevardi, S., McGrath, S., Campbell, B., Lee, H., Herdy, J. R., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.09.001 · Cited by 765
Deuse, T., Hu, X., Gravina, A., Wang, D., Tediashvili, G., De, C., Thayer, W. O., Wahl, A., Garcia, J. V., Reichenspurner, H., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0016-3 · Cited by 758
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
Gornalusse, G. G., Hirata, R. K., Funk, S. E., Riolobos, L., Lopes, V. S., Manske, G., Prunkard, D., Colunga, A. G., Hanafi, L.-A., Clegg, D. O., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3860 · Cited by 639
Generation of induced pluripotent stem cells from human blood
Loh, Y.-H., Agarwal, S., Park, I.-H., Urbach, A., Huo, H., Heffner, G. C., Kim, K., Miller, J. D., Ng, K., & Daley, G. Q. (2009) · Blood · doi:10.1182/blood-2009-02-204800 · Cited by 626
Bar-Nur, O., Russ, H. A., Efrat, S., & Benvenisty, N. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.007 · Cited by 611
Kim, K., Zhao, R., Doi, A., Ng, K., Unternaehrer, J., Cahan, P., Hongguang, H., Loh, Y.-H., Aryee, M. J., Lensch, M. W., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.2052 · Cited by 610
Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., Takada, N., Inoue, M., Hasegawa, M., Kawamata, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103509108 · Cited by 605
Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.003 · Cited by 584
A High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells
Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.003 · Cited by 563
Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
Merkle, F. T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., et al. (2017) · Nature · doi:10.1038/nature22312 · Cited by 506
Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies
Bouvy, J. C., De Bruin, M. L., & Koopmanschap, M. A. (2015) · Drug Safety · doi:10.1007/s40264-015-0281-0 · Cited by 466
Menasché, P., Vanneaux, V., Hagège, A., Bel, A., Cholley, B., Parouchev, A., Cacciapuoti, I., Al-Daccak, R., Benhamouda, N., Blons, H., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.047 · Cited by 456
Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro
Bardy, C., van den Hurk, M., Eames, T., Marchand, C., Hernandez, R. V., Kellogg, M., Gorris, M., Galet, B., Palomares, V., Brown, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504393112 · Cited by 429
Crespo, M., Vilar, E., Tsai, S.-Y., Chang, K., Amin, S., Srinivasan, T., Zhang, T., Pipalia, N. H., Chen, H. J., Witherspoon, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4355 · Cited by 399
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time
Nishino, K., Toyoda, M., Yamazaki-Inoue, M., Fukawatase, Y., Chikazawa, E., Sakaguchi, H., Akutsu, H., & Umezawa, A. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002085 · Cited by 314
Genetic Background Drives Transcriptional Variation in Human Induced Pluripotent Stem Cells
Rouhani, F., Kumasaka, N., de Brito, M. C., Bradley, A., Vallier, L., & Gaffney, D. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004432 · Cited by 294
Ghosh, Z., Wilson, K. D., Wu, Y., Hu, S., Quertermous, T., & Wu, J. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008975 · Cited by 281
Giacomelli, E., Bellin, M., Sala, L., van Meer, B. J., Tertoolen, L. G. J., Orlova, V. V., & Mummery, C. L. (2017) · Development · doi:10.1242/dev.143438 · Cited by 279
Epigenetic Regulation of Pluripotency and Differentiation
Boland, M. J., Nazor, K. L., & Loring, J. F. (2014) · Circulation Research · doi:10.1161/circresaha.115.301517 · Cited by 271
Personalised organs-on-chips: functional testing for precision medicine
van den Berg, A., Mummery, C. L., Passier, R., & van der Meer, A. D. (2019) · Lab on a Chip · doi:10.1039/c8lc00827b · Cited by 270
Modeling human diseases with induced pluripotent stem cells: from 2D to 3D and beyond
Liu, C., Oikonomopoulos, A., Sayed, N., & Wu, J. C. (2018) · Development · doi:10.1242/dev.156166 · Cited by 267
Quality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines
Sullivan, S., Stacey, G. N., Akazawa, C., Aoyama, N., Baptista, R., Bedford, P., Bennaceur Griscelli, A., Chandra, A., Elwood, N., Girard, M., et al. (2018) · Regenerative Medicine · doi:10.2217/rme-2018-0095 · Cited by 265
Ohnuki, M., Tanabe, K., Sutou, K., Teramoto, I., Sawamura, Y., Narita, M., Nakamura, M., Tokunaga, Y., Nakamura, M., Watanabe, A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413299111 · Cited by 263
Musunuru, K., Sheikh, F., Gupta, R. M., Houser, S. R., Maher, K. O., Milan, D. J., Terzic, A., & Wu, J. C. (2018) · Circulation: Genomic and Precision Medicine · doi:10.1161/hcg.0000000000000043 · Cited by 229
Zhao, T., Zhang, Z.-N., Westenskow, P. D., Todorova, D., Hu, Z., Lin, T., Rong, Z., Kim, J., He, J., Wang, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.021 · Cited by 226
Modeling Familial Cancer with Induced Pluripotent Stem Cells
Lee, D.-F., Su, J., Kim, H. S., Chang, B., Papatsenko, D., Zhao, R., Yuan, Y., Gingold, J., Xia, W., Darr, H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.02.045 · Cited by 224
Influence of donor age on induced pluripotent stem cells
Lo Sardo, V., Ferguson, W., Erikson, G. A., Topol, E. J., Baldwin, K. K., & Torkamani, A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3749 · Cited by 223
Efficient Detection and Purification of Cell Populations Using Synthetic MicroRNA Switches
Miki, K., Endo, K., Takahashi, S., Funakoshi, S., Takei, I., Katayama, S., Toyoda, T., Kotaka, M., Takaki, T., Umeda, M., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.04.005 · Cited by 218
Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors
Narsinh, K. H., Jia, F., Robbins, R. C., Kay, M. A., Longaker, M. T., & Wu, J. C. (2011) · Nature Protocols · doi:10.1038/nprot.2010.173 · Cited by 214
Bellin, M., Casini, S., Davis, R. P., D'Aniello, C., Haas, J., Ward-van Oostwaard, D., Tertoolen, L. G. J., Jung, C. B., Elliott, D. A., Welling, A., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.240 · Cited by 196
Programming and Reprogramming Cellular Age in the Era of Induced Pluripotency
Studer, L., Vera, E., & Cornacchia, D. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.004 · Cited by 187
Present and future challenges of induced pluripotent stem cells
Ohnuki, M., & Takahashi, K. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0367 · Cited by 174
Kotini, A. G., Chang, C.-J., Boussaad, I., Delrow, J. J., Dolezal, E. K., Nagulapally, A. B., Perna, F., Fishbein, G. A., Klimek, V. M., Hawkins, R. D., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3178 · Cited by 171
de Almeida, P. E., Meyer, E. H., Kooreman, N. G., Diecke, S., Dey, D., Sanchez-Freire, V., Hu, S., Ebert, A., Odegaard, J., Mordwinkin, N. M., et al. (2014) · Nature Communications · doi:10.1038/ncomms4903 · Cited by 170
Mattapally, S., Pawlik, K. M., Fast, V. G., Zumaquero, E., Lund, F. E., Randall, T. D., Townes, T. M., & Zhang, J. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010239 · Cited by 170
Doss, M. X., Di Diego, J. M., Goodrow, R. J., Wu, Y., Cordeiro, J. M., Nesterenko, V. V., Barajas-Martínez, H., Hu, D., Urrutia, J., Desai, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040288 · Cited by 169
Self-citationMatsa, E., Burridge, P. W., Yu, K.-H., Ahrens, J. H., Termglinchan, V., Wu, H., Liu, C., Shukla, P., Sayed, N., Churko, J. M., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.07.006 · Cited by 164
Patient-derived induced pluripotent stem cells in cancer research and precision oncology
Papapetrou, E. P. (2016) · Nature Medicine · doi:10.1038/nm.4238 · Cited by 160
Immunogenicity of Pluripotent Stem Cells and Their Derivatives
de Almeida, P. E., Ransohoff, J. D., Nahid, A., & Wu, J. C. (2013) · Circulation Research · doi:10.1161/circresaha.111.249243 · Cited by 159
Kotini, A. G., Chang, C.-J., Chow, A., Yuan, H., Ho, T., Wang, T., Vora, S., Solovyov, A., Husser, C., Olszewska, M., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.01.009 · Cited by 158
Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA
Warren, L., Ni, Y., Wang, J., & Guo, X. (2012) · Scientific Reports · doi:10.1038/srep00657 · Cited by 154
Stricker, S. H., Feber, A., Engström, P. G., Carén, H., Kurian, K. M., Takashima, Y., Watts, C., Way, M., Dirks, P. B., Bertone, P., et al. (2013) · Genes & Development · doi:10.1101/gad.212662.112 · Cited by 144
Addressing the ethical issues raised by synthetic human entities with embryo-like features
Aach, J., Lunshof, J. E., Iyer, E. P. R., & Church, G. M. (2017) · eLife · doi:10.7554/elife.20674 · Cited by 141
Correia, C., Koshkin, A., Duarte, P., Hu, D., Carido, M., Sebastião, M. J., Gomes‐Alves, P., Elliott, D. A., Domian, I. J., Teixeira, A. P., et al. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26504 · Cited by 139
‘Reprogrammed’ stem cells approved to mend human hearts for the first time
Cyranoski, D. (2018) · Nature · doi:10.1038/d41586-018-05278-8 · Cited by 132
Organs-on-chips: Progress, challenges, and future directions
Low, L. A., & Tagle, D. A. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217700523 · Cited by 131
Pearson, B. L., Simon, J. M., McCoy, E. S., Salazar, G., Fragola, G., & Zylka, M. J. (2016) · Nature Communications · doi:10.1038/ncomms11173 · Cited by 127
Embryonic stem cells: a promising tool for cell replacement therapy
Doss, M. X., Koehler, C. I., Gissel, C., Hescheler, J., & Sachinidis, A. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00471.x · Cited by 126
Self-citationSuicide Gene Therapy for Cancer; Old Dog New Tricks
Zarogoulidis, P. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000139 · Cited by 125
Atchison, L., Zhang, H., Cao, K., & Truskey, G. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-08632-4 · Cited by 125
Biomechanical Strain Exacerbates Inflammation on a Progeria‐on‐a‐Chip Model
Ribas, J., Zhang, Y. S., Pitrez, P. R., Leijten, J., Miscuglio, M., Rouwkema, J., Dokmeci, M. R., Nissan, X., Ferreira, L., & Khademhosseini, A. (2017) · Small · doi:10.1002/smll.201603737 · Cited by 120
Kusumoto, D., Lachmann, M., Kunihiro, T., Yuasa, S., Kishino, Y., Kimura, M., Katsuki, T., Itoh, S., Seki, T., & Fukuda, K. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.04.007 · Cited by 111
ALS disrupts spinal motor neuron maturation and aging pathways within gene co-expression networks
Ho, R., Sances, S., Gowing, G., Mathis, M. W., O’Rourke, J. G., Sahabian, A., Wichterle, H., Baloh, R. H., Sareen, D., & Svendsen, C. N. (2016) · Nature Neuroscience · doi:10.1038/nn.4345 · Cited by 110
Gunaseeli, I., Doss, M. X., Antzelevitch, C. N., Hescheler, J., & Sachinidis, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790514480 · Cited by 104
Self-citationGeneration of human induced pluripotent stem cells from oral mucosa
Miyoshi, K., Tsuji, D., Kudoh, K., Satomura, K., Muto, T., Itoh, K., & Noma, T. (2010) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2010.03.004 · Cited by 98
miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2
Pfaff, N., Fiedler, J., Holzmann, A., Schambach, A., Moritz, T., Cantz, T., & Thum, T. (2011) · EMBO Reports · doi:10.1038/embor.2011.176 · Cited by 96
Unique Metabolic Features of Stem Cells, Cardiomyocytes, and Their Progenitors
Gaspar, J. A., Doss, M. X., Hengstler, J. G., Cadenas, C., Hescheler, J., & Sachinidis, A. (2014) · Circulation Research · doi:10.1161/circresaha.113.302021 · Cited by 93
Self-citationChaudhari, U., Nemade, H., Gaspar, J. A., Hescheler, J., Hengstler, J. G., & Sachinidis, A. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1668-0 · Cited by 90
Self-citationMulero-Navarro, S., Sevilla, A., Román, A.-C., Lee, D.-F., D'Souza, S., Pardo, S., Riess, I., Su, J., Cohen, N., Schaniel, C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.019 · Cited by 83
Kim, M., Rhee, J., Choi, H., Kwon, A., Kim, J., Lee, D., Jekarl, D. W., Lee, S., Kim, Y., & Kim, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-15155-5 · Cited by 83
iPS-Cell Technology and the Problem of Genetic Instability—Can It Ever Be Safe for Clinical Use?
Attwood, S., & Edel, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030288 · Cited by 82
Dambrot, C., Braam, S. R., Tertoolen, L. G. J., Birket, M. J., Atsma, D. E., & Mummery, C. L. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12356 · Cited by 70
Nemade, H., Chaudhari, U., Acharya, A., Hescheler, J., Hengstler, J. G., Papadopoulos, S., & Sachinidis, A. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2170-7 · Cited by 65
Self-citationBravery, C. A. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0136 · Cited by 64
Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism
Kim, H., Yoo, S., Zhou, R., Xu, A., Bernitz, J. M., Yuan, Y., Gomes, A., Daniel, M. G., Su, J., Demicco, E. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814044115 · Cited by 62
Strategy for the creation of clinical grade hESC line banks that HLA‐match a target population
Jacquet, L., Stephenson, E., Collins, R., Patel, H., Trussler, J., Al‐bedaery, R., Renwick, P., Ogilvie, C. M., Vaughan, R., & Ilić, D. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201973 · Cited by 56
Urine-derived cells provide a readily accessible cell type for feeder-free mRNA reprogramming
Gaignerie, A., Lefort, N., Rousselle, M., Forest, V. F., Flippe, L., François-Campion, V., Girardeau, A., Caillaud, A., Chariau, C., Francheteau, Q., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32645-2 · Cited by 53
Zhou, R., Xu, A., Gingold, J. A., Strong, L. C., Zhao, R., & Lee, D. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.07.004 · Cited by 52
Chaudhari, U., Ellis, J. K., Wagh, V., Nemade, H., Hescheler, J., Keun, H. C., & Sachinidis, A. (2017) · Amino Acids · doi:10.1007/s00726-017-2419-0 · Cited by 43
Self-citationDerivation of Induced Pluripotent Stem Cells from Human Peripheral Circulating T Cells
Seki, T., Yuasa, S., & Fukuda, K. (2011) · Current Protocols in Stem Cell Biology · doi:10.1002/9780470151808.sc04a03s18 · Cited by 42
How human embryonic stem cells sparked a revolution
Cyranoski, D. (2018) · Nature · doi:10.1038/d41586-018-03268-4 · Cited by 42
Using induced pluripotent stem cells as a tool for modelling carcinogenesis
Curry, E. L. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.461 · Cited by 40
Shinde, V., Sureshkumar, P., Sotiriadou, I., Hescheler, J., & Sachinidis, A. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160627113436 · Cited by 40
Self-citationModeling APC mutagenesis and familial adenomatous polyposis using human iPS cells
Sommer, C. A., Capilla, A., Molina-Estevez, F. J., Gianotti-Sommer, A., Skvir, N., Caballero, I., Chowdhury, S., & Mostoslavsky, G. (2018) · PLOS ONE · doi:10.1371/journal.pone.0200657 · Cited by 39
Roadblocks in the Path of iPSC to the Clinic
Garreta, E., Sánchez‐Bautista, S., Lajara, J., Montserrat, N., & Belmonte, J. C. I. (2018) · Current Transplantation Reports · doi:10.1007/s40472-018-0177-x · Cited by 39
Modeling Cancer with Pluripotent Stem Cells
Gingold, J. A., Zhou, R., Lemischka, I. R., & Lee, D. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.07.007 · Cited by 37
Chaudhari, U., Nemade, H., Sureshkumar, P., Vinken, M., Ates, G., Rogiers, V., Hescheler, J., Hengstler, J. G., & Sachinidis, A. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2065-z · Cited by 36
Self-citationDambrot, C., van de Pas, S., van Zijl, L., Brändl, B., Wang, J., Schalij, M. J., Hoeben, R. C., Atsma, D. E., Mikkers, H. M. M., Mummery, C. L., et al. (2013) · Differentiation · doi:10.1016/j.diff.2013.01.001 · Cited by 32
Yan, Y., Bejoy, J., Xia, J., Griffin, K., Guan, J., & Li, Y. (2019) · Scientific Reports · doi:10.1038/s41598-018-37686-1 · Cited by 27
A Cancer Reprogramming Method Using MicroRNAs as a Novel Therapeutic Approach against Colon Cancer
Miyazaki, S., Yamamoto, H., Miyoshi, N., Wu, X., Ogawa, H., Uemura, M., Nishimura, J., Hata, T., Takemasa, I., Mizushima, T., et al. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4217-1 · Cited by 25
Induced pluripotent stem cells: a new tool for toxicology screening?
Heng, B. C., Richards, M., Shu, Y., & Gribbon, P. M. (2009) · Archives of Toxicology · doi:10.1007/s00204-009-0414-2 · Cited by 25
Key Anticipated Regulatory Issues for Clinical Use of Human Induced Pluripotent Stem Cells
Knoepfler, P. S. (2012) · Regenerative Medicine · doi:10.2217/rme.12.51 · Cited by 24
Huang, K., Liu, P., Li, X., Chen, S., Wang, L., Qin, L., Su, Z., Huang, W., Liu, J., Jia, B., et al. (2014) · Science China Life Sciences · doi:10.1007/s11427-013-4598-6 · Cited by 21
Reprogramming cancer cells to pluripotency: An experimental tool for exploring cancer epigenetics
Stricker, S. H., & Pollard, S. M. (2014) · Epigenetics · doi:10.4161/epi.28600 · Cited by 19
Schork, N. J., & Nazor, K. L. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.06.001 · Cited by 16
Eschenhagen, T., & Weinberger, F. (2019) · Circulation Research · doi:10.1161/circresaha.118.314336 · Cited by 14
Cited by
Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications
Liu, G., David, B. T., Trawczynski, M., & Fessler, R. G. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09935-x · Cited by 519
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Cerneckis, J., Cai, H., & Shi, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01809-0 · Cited by 452
Microglia: Agents of the CNS Pro-Inflammatory Response
Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365
A Brief Overview of Global Trends in MSC-Based Cell Therapy
Jovic, D., Yu, Y., Wang, D., Wang, K., Li, H., Xu, F., Liu, C., Liu, J., & Luo, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10369-1 · Cited by 286
Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis
Blaser, M. C., Kraler, S., Lüscher, T. F., & Aikawa, E. (2021) · Circulation Research · doi:10.1161/circresaha.120.317979 · Cited by 109
Metadata
- Authors
- Doss, M. X., & Sachinidis, A.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-04-30
- Volume
- 8
- Issue
- 5
- Pages
- 403
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2942799604
- Cited by
- 456
- References
- 110
- FWCI
- 14.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.